Cogent Biosciences, Inc. (COGT)
Cogent Biosciences Market Cap : 5.708B for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Syndax Pharmaceuticals, Inc. | 2.336B |
| Vera Therapeutics, Inc. | 2.936B |
| Terns Pharmaceuticals, Inc. | 6.077B |
| Nuvalent, Inc. | 8.272B |
| Insmed, Inc. | 34.50B |
Market Cap Related Metrics
| Price to Book Value | 10.45 |
| Price | 35.21 |
| Earnings Yield | -6.95% |